Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.71 |
| ▸ | MEN1 | O00255 | 5/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.69 |
| ▸ | LMNA | P02545 | 4/20 | 0.69 |
| ▸ | THRA | P10827 | 1/20 | 0.69 |
| ▸ | THRB | P10828 | 1/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | RXRA | P19793 | 1/20 | 0.50 |
| ▸ | RXRB | P28702 | 1/20 | 0.50 |
| ▸ | RXRG | P48443 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30514209 | 0.97 | ALDH1A1 (0.67) | ALDH1A1MEN1KMT2ALMNATHRA | |
| SCHEMBL4866699 | 0.97 | ALDH1A1 (0.67) | ALDH1A1MEN1KMT2ALMNATHRA | |
| SCHEMBL3066269 | 0.84 | ALDH1A1 (0.78) | ALDH1A1MEN1KMT2ALMNATHRA | |
| SCHEMBL4005306 | 0.84 | ALDH1A1 (0.71) | ALDH1A1MEN1KMT2ALMNATHRA | |
| SCHEMBL10800952 | 0.82 | MEN1 (0.74) | ALDH1A1MEN1KMT2ALMNATHRA | |
| SCHEMBL6318160 | 0.82 | ALDH1A1 (0.68) | ALDH1A1MEN1KMT2ALMNATHRA | |
| SCHEMBL6627140 | 0.80 | ALDH1A1 (0.65) | ALDH1A1MEN1KMT2ALMNATHRA | |
| SCHEMBL6627142 | 0.80 | ALDH1A1 (0.65) | ALDH1A1MEN1KMT2ALMNATHRA | |
| SCHEMBL3014533 | 0.80 | ALDH1A1 (0.65) | ALDH1A1MEN1KMT2ALMNATHRA | |
| SCHEMBL6187673 | 0.80 | ALDH1A1 (0.54) | ALDH1A1MEN1KMT2ALMNATHRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11332452-B2 | Pesticidal compositions and methods | CORTEVA AGRISCIENCE LLC (US) | 2022-05-17 | — | — | US | disclosed |
| US-11297838-B2 | Pesticidal compositions and methods | CORTEVA AGRISCIENCE LLC (US) | 2022-04-12 | — | — | US | disclosed |
| US-20210282402-A1 | PESTICIDAL COMPOSITIONS AND METHODS | DOW AGROSCIENCES LLC (US) | 2021-09-16 | — | — | US | disclosed |
| US-20210276963-A1 | PESTICIDAL COMPOSITIONS AND METHODS | DOW AGROSCIENCES LLC (US) | 2021-09-09 | — | — | US | disclosed |
| WO-2020163146-A1 | PESTICIDAL COMPOSITIONS AND METHODS | DOW AGROSCIENCES LLC (US) | 2020-08-13 | — | — | WO | disclosed |
| WO-2020139566-A1 | PESTICIDAL COMPOSITIONS AND METHODS | DOW AGROSCIENCES LLC (US) | 2020-07-02 | — | — | WO | disclosed |
| US-7407960-B2 | Substituted heterocyclic compounds | CV THERAPEUTICS, INC. (US) | 2008-08-05 | — | — | US | disclosed |
| EP-1806346-A1 | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors | CV THERAPEUTICS, INC. (US) | 2007-07-11 | — | — | EP | disclosed |
| US-20070004751-A1 | Substituted heterocyclic compounds | ELZEIN ELFATIH | 2007-01-04 | — | — | US | disclosed |
| US-7125876-B2 | Substituted heterocyclic compounds | CV THERAPEUTICS, INC. (US) | 2006-10-24 | — | — | US | disclosed |
| US-20040152890-A1 | Substituted heterocyclic compounds | CV THERAPEUTICS, INC. | 2004-08-05 | — | — | US | disclosed |
| US-3936293-A | PLANT GROWTH REGULATORS | CIBA-GEIGY CORPORATION (US) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11297838-B2 | Pesticidal compositions and methods | ACHE, DDT, PLA2G2D | ALDH1A1 762/4885MEN1 1670/4885KMT2A 1768/4885 |
| US-20210276963-A1 | PESTICIDAL COMPOSITIONS AND METHODS | ACHE, DDT, PLA2G2D | ALDH1A1 762/4885MEN1 1670/4885KMT2A 1768/4885 |
| US-11332452-B2 | Pesticidal compositions and methods | ACHE, DDT, PLA2G2D | ALDH1A1 762/4885MEN1 1670/4885KMT2A 1768/4885 |
| US-20040152890-A1 | Substituted heterocyclic compounds | KCNH1, SDHA, COQ8A | ALDH1A1 245/4885MEN1 3200/4885KMT2A 3201/4885 |
| US-20070004751-A1 | Substituted heterocyclic compounds | KCNH1, SDHA, COQ8A | ALDH1A1 281/4885MEN1 2899/4885KMT2A 3029/4885 |
| US-20210282402-A1 | PESTICIDAL COMPOSITIONS AND METHODS | ACHE, DDT, PLA2G2D | ALDH1A1 762/4885MEN1 1670/4885KMT2A 1768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.